Technical

Stemedica Cell Technologies, Inc., a US company with investment from JZT, started recruiting patients for its Phase II COVID-19 study.


Stemedica Cell Technologies, Inc., a US company with investment from JZT, started recruiting patients for its Phase II COVID-19 study.